Press Releases
How are advancements in technology reshaping the roles and capabilities of CDMOs and CROs in the drug development life cycle?
In today’s rapidly evolving drug development landscape, partnership between innovative biopharmaceutical companies and resource-rich CDMOs is vital for ensuring global access to essential medicines. In these roundtable discussions, our project manager, Jaewon Mun offers her insights on how advanced technologies and customizable models enable CDMOs to provide enhanced support throughout the drug development life cycle, ultimately driving client success.
In today’s rapidly evolving drug development landscape, partnership between innovative biopharmaceutical companies and resource-rich CDMOs is vital for ensuring global access to essential medicines. In these roundtable discussions, our project manager, Jaewon Mun offers her insights on how advanced technologies and customizable models enable CDMOs to provide enhanced support throughout the drug development life cycle, ultimately driving client success.